Azar: Let Medicare Part B Negotiate Drug Prices

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Al7aH0 on November 30, 2017 at 05:07PM

CMS_fundingopportunityPresident Donald Trump’s pick to replace Tom Price as the Health and Human Services secretary, Alex Azar, says the Medicare Part B program should be allowed to negotiate drug prices.

Azar made the comments during a Senate Committee on Health, Education, Labor and Pensions hearing Wednesday.

Currently, According to a Medical Marketing and Media reports, the Medicare Part D program can negotiate drug prices.

Azar during the hearing said he wanted to “take the learnings from Part D to Part B.”

“Part D has negotiations with the biggest PBMs, and secures the best net prices of any player in the commercial system,” Azar said.

Click here to read the full write up on MM&M.